+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GLAXO

GlaxoSmithKline Pharmaceuticals Share Price

₹2,655.40 +44.7 (1.71%)
27.17% Gain from 52W Low

31 Jul, 2026 3:59 PM (IST)

GlaxoSmithKline Pharmaceuticals live price: ₹2,655.40. It opened at ₹2,618 vs previous close ₹2,611; intraday high/low: ₹2,679/₹2,565. The 50 & 200 DMA stand at ₹2,434.70/₹2,476.00.

GlaxoSmithKline Pharmaceuticals Performance

  • Today's Low
  • ₹2,565
  • Today's High
  • ₹2,679
  • 52 Week Low
  • ₹2,088
  • 52 Week High
  • ₹3,184
  • Open Price₹2,618
  • Previous Close₹2,611
  • Volume121,325
  • 50 DMA₹2,434.70
  • 100 DMA₹2,423.60
  • 200 DMA₹2,476.00

GlaxoSmithKline Pharmaceuticals Chart

Investment Returns

  • Over 1 Month + 8.37%
  • Over 3 Month + 13.65%
  • Over 6 Month + 10.57%
  • Over 1 Year -16.04%

Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!

Invest Now

GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 43.4
  • PEG Ratio
  • 3.7
  • Market Cap Cr
  • 44,984
  • P/B Ratio
  • 19.8
  • Average True Range
  • 69.4
  • EPS
  • 61.2
  • Dividend Yield
  • 2.1
  • MACD Signal
  • 70.2
  • RSI
  • 70.65
  • MFI
  • 77.73

Latest Stock News Updates

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

As per attachment

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Intimation for Approve And Take On Record The Un-Audited Financial Results For The First Quarter Ended 30Th June 2026.

Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve approve and take on record the Un-audited financial results for the first quarter ended 30th June 2026.

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

As per attachment

GlaxoSmithKline Pharmaceuticals Financials

GlaxoSmithKline Pharmaceuticals Technicals

EMA & SMA

Current Price
₹2,655.40
+ 44.7 (1.71%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹2,515.30
  • 50 Day
  • ₹2,434.70
  • 100 Day
  • ₹2,423.60
  • 200 Day
  • ₹2,476.00

Resistance and Support

2633.03 Pivot Speed
  • R3 2,815.70
  • R2 2,747.30
  • R1 2,701.40
  • S1 2,587.10
  • S2 2,518.70
  • S3 2,472.80

GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-03 Quarterly Results
2026-05-13 Audited Results & Dividend
2026-02-09 Quarterly Results
2025-11-06 Quarterly Results
2025-08-01 Quarterly Results
Date Purpose Remarks
2026-05-29 FINAL Rs.57.00 per share(570%)Final Dividend
2025-05-30 FINAL Rs.42.00 per share(420%)Final Dividend
2024-11-07 INTERIM Rs.12.00 per share(120%)Interim Dividend
2024-05-31 FINAL Rs.32.00 per share(320%)Final Dividend
2023-06-30 FINAL Rs.32.00 per share(320%)Final Dividend
View GlaxoSmithKline Pharmaceuticals Dividend History Arrow

GlaxoSmithKline Pharmaceuticals Shareholding Pattern

75%
12.42%
4.87%
4.79%
2.94%

About GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals. View More
  • NSE Symbol
  • GLAXO
  • BSE Symbol
  • 500660
  • ISIN
  • INE159A01016

Similar Stocks to GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals FAQs

GlaxoSmithKline Pharmaceuticals share price is ₹2,655 As on 02 August, 2026 | 06:37

The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹44984.1 Cr As on 02 August, 2026 | 06:37

The P/E ratio of GlaxoSmithKline Pharmaceuticals is 43.4 As on 02 August, 2026 | 06:37

The PB ratio of GlaxoSmithKline Pharmaceuticals is 19.8 As on 02 August, 2026 | 06:37

The 52 week High & Low of GlaxoSmithKline Pharmaceuticals is ₹3184.3/₹2088.1 respectively As on 02 August, 2026 | 06:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23